These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2457664)

  • 1. Clinical experience with the carbohydrate antigen CA-50 in the serum of patients with prostatic carcinoma: a preliminary report.
    Melloni D; Cacciatore M; Carreca I; Cigno A; Laconi A; Pavone-Macaluso M
    J Exp Pathol; 1987; 3(4):369-73. PubMed ID: 2457664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic-specific antigen].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(3):159-60. PubMed ID: 2456711
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostatic intraepithelial neoplasia and prostate-specific antigen.
    Brawer MK
    Urology; 1989 Dec; 34(6 Suppl):62-5. PubMed ID: 2481364
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor associated markers as organ-specific antigens of the human seminal plasma. II. Immunohistological studies].
    Dienst C; Uhlenbruck G; Heising J; Höller U; Dreessen C
    Z Hautkr; 1985 Jan; 60(1-2):157-64. PubMed ID: 2580399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF; Mensink HJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of prostate-specific antigen in urologic pathology. Preliminary results].
    Morote Robles J; Genollar Subirats J
    Arch Esp Urol; 1985; 38(6):562-6. PubMed ID: 2421651
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
    Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
    Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the serum determination of specific prostatic antigen in the prediction of prostatic cancer].
    Morote Robles J; Ruibal Morell A; Pont Salvadó A
    Actas Urol Esp; 1988; 12(1):10-4. PubMed ID: 2455436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Misleading figures concerning PSA and health examination].
    Fager PJ
    Lakartidningen; 1991 Sep; 88(38):3065-6. PubMed ID: 1717799
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer: new hope for early diagnosis.
    Cooner WH; Eggers GW; Lichtenstein P
    Ala Med; 1987 Jun; 56(12):13-6. PubMed ID: 2441583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
    Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with prostate-specific antigen in patients with prostatic cancer].
    Romics I; Bach D
    Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?].
    Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D
    Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostate-specific antigen: contribution of monoclonal antibodies to its plasma determination by radioimmunoassay].
    Gutiérrez Mínguez E; García Talavera JR; Martín Rodríguez M; Sánchez González ML; Díaz Alférez FJ; Urrutia Avisrror M
    Arch Esp Urol; 1988 Apr; 41(3):188-92. PubMed ID: 2456746
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
    Ware JL; Paulson DF; Parks SF; Webb KS
    Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
    Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
    Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.